Login / Signup

Triggered or routine site monitoring visits for randomised controlled trials: results of TEMPER, a prospective, matched-pair study.

Sally P StenningWilliam J CraggNicola JoffeCarlos Diaz-MontanaRahela ChoudhuryMatthew Robert SydesSarah Meredith
Published in: Clinical trials (London, England) (2018)
Triggered monitoring approaches, as used in these trials, were not sufficiently discriminatory. The rate of Major and Critical findings was higher than anticipated, but the majority related to consent and re-consent with no indication of systemic problems that would impact trial-wide safety issues or integrity of the results in any of the three trials. Sensitivity analyses suggest triggered monitoring may be of potential use, but needs improvement and investigation of further central monitoring triggers is warranted. TEMPER highlights the need to question and evaluate methods in trial conduct, and should inform further developments in this area.
Keyphrases
  • clinical trial
  • study protocol
  • phase iii
  • mental health
  • phase ii
  • clinical practice
  • climate change
  • drug induced
  • double blind